昱展新藥首頁橫幅1
昱展新藥首頁橫幅
index-slider-b
previous arrow
next arrow

ALAR , Light up Your Life

Recent Alar News

13 January, 2022

Alar Announces Significant Progress on Developing long-acting Buprenorphine
Injectable ALA-1000.

09 November, 2021

Alar Announce Results from ALA-1000 Single Ascending Dose Study in Opioid Dependent Patients.

28 October, 2021

Alar Pharmaceuticals Inc. Completes Successful End-of-Phase 2 Meeting with US FDA for ALA-1000 for the Treatment of Opioid Use Disorder

16 August, 2021

Alar Pharmaceuticals Announces H1 Financial Results